A method (400) of manufacturing a wound dressing includes obtaining alginate fibers (108) and the step (404) of spraying either the alginate fibers (108) or a dressing or dressing layer (610) of the alginate fibers with an aqueous solution (801) comprising a polysaccharide, which can be carboxymethylcellulose. The step of spraying can occur while the alginate fibers, dressing, or dressing layer are wet. A step (405) of flash drying can follow to remove the solute of the aqueous solution to leave the polysaccharide along the alginate. The step of spraying can be selective, such that only portions of the dressing layer include the polysaccharide.

An absorbent article that includes an outer covering made of two liquid-permeable cover layers that are joined together to form a pocket, and an inner layer that is initially freely movable within the pocket. The inner layer includes a mixture of particles of a superabsorbent polymer and substances that are osmotically comparatively weaker than the particles. When the absorbent article is applied to a human or animal skin surface to cover a wound, the absorbent article exerts an osmotic pressure via which endogenous wound exudate is removed from the wound. Thus, the absorbent article assists, both in a surface region and in a tissue depth, a normal interstitial hydration of the tissue by directing the wound fluids in a direction of flow to the skin surface and into the absorbent article, and by keeping the wound fluids that flow to the skin surface in the absorbent article.

Wound dressings and wound inserts comprising substantially dry reactive agents, methods of forming wound inserts comprising dry reactive agents, and wound-treatment methods.

This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.

Wound dressings and wound inserts comprising substantially dry reactive agents, methods of forming wound inserts comprising dry reactive agents, and wound-treatment methods.

An article for therapy and treatment of at least one eye. The article includes a backing for application to the at least one eye. The backing includes at least one receiver positioned to align with the at least one eye. The article also includes at least one pod that is detachably secured within the at least one receiver. The at least one pod includes material for delivering therapy and treatment to the at least one eye.

The invention provides a solid foam wound dressing useful for hemorrhage control and wound repair, as well as methods for making such a wound dressing.

A device for sealing and securing a catheter at its insertion site in order to provide for optimum safe catheter function, and to achieve maximum catheter longevity/dwell time is described. The sterile seal achieved by this device fully protects the catheter and its insertion site from external contamination. The unique sterile seal also functions to fully stabilize and secure the catheter, thereby minimizing traumatic catheter injury and loss. A means of continuously viewing the insertion site is also provided, as well as mechanisms for maintaining sterility of the sterile chamber that is formed around the catheter insertion site by the integrated sealing and securing device. Together these features allow for improved catheter safety and function, and allow catheters to safely remain in place for an extended period of time. The need to change catheter dressings at intervals is minimized or eliminated.

This invention relates to a pharmaceutical preparation for the treatment of compromised tissue such as skin wounds and ulcers in humans and animals and a method of preparation. This is a multifunctional natural matrix meant for the treatment of compromised tissues which also relates to the anti-cancer transdermal patch for melanoma therapy. Further, the invention comprises for the treatment of Alzheimer's, and multiple sclerosis also. The composition consists of water-solubilized nano-sized formulation of non-aqueous solvent extract of phyto-pharmaceuticals in herbal, animal or synthetic biocompatible gel or on matrix coated or both. The composition is used as a topical device for the treatment of compromised tissues in its preferred embodiment.

A wound dressing including at least one layer made of microbially produced cellulose formed into a biocellulose layer, wherein the wound dressing is configured to adsorb bacteria and wherein the thickness of the bio-cellulose layer is between 0.08 and 1.5 mm, as well as a method for producing such a wound dressing.